To combat long-overlooked fungal pathogens, researchers and regulators must embrace innovative science and policy.

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...

We evaluated the cardiac effect of azole antifungals, specifically ITZ, and possible mechanisms of toxicity. Ex vivo live-heart studies were performed utilizing Sprague Dawley rats. Short exposure (5 ...

The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome ...

tropicalis and other fungi are of growing concern as many of these pathogens are becoming increasingly resistant to antifungal medicines. However, the biological mechanisms underlying this ...

Scientists uncovered how whole-genome duplication emerges and remains stable over thousands of generations of evolution in the lab. Sometimes, the most significant scientific discoveries happen by ...

The study demonstrates that this RNAi approach shuts down vital fungal genes, thereby inhibiting pathogen growth - a groundbreaking step in the development of new antifungal therapies. (Nanowerk News) ...

Antifungals are the first-line treatment for fungal infections such as TMVII. This may include oral antifungal medications. However, this is an emerging illness, and large studies on the best ...

auris, as it not only is highly resistant to multiple antifungal drugs but also can withstand common hospital disinfectants. “CDC has deemed C. auris as an urgent AR [antimicrobial resistance ...